Traditional Chinese Medicine AI-Assisted Diagram

Strengths

• High scarcity of evidence-based databases for classical formulas by renowned practitioners such as Huang Huang
• Real-world diagnosis and treatment data closed-loop brought by chain scenarios like Gushentang
• TCM AI going global opens up incremental markets in Southeast Asia, Europe, and the Americas

Weaknesses

• Significant controversy over TCM standardization, with unclear liability subjects for AI diagnosis
• Cross-institution prescription data sharing restricted by privacy regulations

Opportunities

• Vast number of primary care TCM clinics with a clear, rigid demand for AI-assisted diagnosis and treatment
• Approval of classical formula preparations requires evidence-based data, increasing licensing demand

Threats

• Rapid evolution of general large language models squeezing the space for vertical TCM SaaS
• Intensified competition for exclusive resources of renowned practitioners, increasing licensing costs